Abiopharma

(99% Neutral) LA ROSA HOLDINGS CORP. (LRHC) Announces Business Combination

New Form 3/A - VCI Global Ltd <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001213900-26-046469 <b>Size:</b> 3 KB

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

PONY AI Inc. Files Its Annual Report on Form 20-F and Publishes Inaugural Environmental, Social and Governance Report

General Announcement: Business Update - Clarification of Transactions

(99% Positive) PICARD MEDICAL, INC. (PMI) Reports Q2 2026 Financial Results

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001213900-26-046466 <b>Size:</b> 2 MB

New Form 3/A - VCI Global Ltd <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001213900-26-046467 <b>Size:</b> 3 KB

Otitoju Kolawole A. 🟢 acquired 257.0K shares (2 derivative) of 908 Devices Inc. (MASS) at $7.26 ($1.1M) Transaction Date: Apr 21, 2026 | Filing ID: 000004

(30% Negative) BCB BANCORP INC (BCBP) Reports Q2 2026 Financial Results

New Form ARS - Consolidated Water Co. Ltd. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001104659-26-046534 <b>Size:</b> 2 MB

Johnson & Johnson - IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026

Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy To Be Released at the 2026 ASCO Annual Meeting

New Form DEFA14A - GARMIN LTD <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001308179-26-000319 <b>Size:</b> 9 MB